About
Gene Editing, Gene Expression, Bioprocessing
Areas of Focus
Categories
Non-PharmaceuticalMidwest
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
2,672
By Phase
PHASE2: 5PHASE1: 7PHASE3: 2
By Status
COMPLETED: 12UNKNOWN: 1TERMINATED: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04046939Lead Sponsor
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
PHASE2Completed
534 participants
Started: Aug 15, 2019 · Completed: Mar 2, 2021
NCT02217332Lead Sponsor
Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
PHASE2Completed
20 participants
Started: Aug 31, 2014 · Completed: Jan 20, 2017
NCT02101138Collaborator
Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
PHASE2Unknown
15 participants
Started: Mar 14, 2014 · Completed: Oct 23, 2019
NCT01607034Lead Sponsor
Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects
PHASE1Completed
24 participants
Started: Jun 30, 2012 · Completed: Jul 31, 2012
NCT01622088Lead Sponsor
Phase 3 Extension Study of Dexpramipexole in ALS
PHASE3Terminated
616 participants
Started: Jun 30, 2012 · Completed: Feb 28, 2013
Locations (1)
Headquarters
St. Louis, MO, United States
Map
Loading map...